Work

PIM Kinase Inhibitor, PIM447, Decreases Cancer Cell Stemness And Exhibits Synergy With Cisplatin In Hepatoblastoma

Year: 2021

Type: article

Source: PEDIATRICS

DOI: 10.1542/peds.147.3ma10.946

Authors: Nikita Wadhwani, Raoud Marayati, Colin H. Quinn, Laura V. Bownes, Jamie M. Aye, Jerry E. Stewart, Karina J. Yoon, Elizabeth A. Beierle

Institution: University of Alabama at Birmingham

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4322723638

FWCI:

Cites:

Cited by:

Related to: 10